ReviewOncology letters2023

Ubiquitin C‑terminal hydrolase‑L1: A new cancer marker and therapeutic target with dual effects (Review).

Xiaowei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.